Tag: vaccines

Bacterial DNA a major worry in Jabs

We know about the species of Bacteria used in filthy toxic soups in the production mRNA Jabs, but it appears some people are confused about the extremely high risk of Bacterial DNA contamination in the vile vials and how that varies Lot to Lot.2

Imagine you are swimming inside a vat when they add Sodium Hydroxide to make the live bacteria spill their guts to yield the desired circular Plasmid double stranded DNA. You need to think of the Bacterial DNA which is rolled up into a tight little Nucleoid ball creating delight for topologists plus all the other toxins liberated.3

How effective is the filtration? We know Bacterial DNA is “nicked” by the alkali and even mechanical handling. What tests have been done by Regulatory Authorities.

Have all test results been redacted?

How much Bacterial DNA has been found by indepedent labs?

When BioNTech applied for Emergency Use Authorization in 2020, the scientists assessing the Process 2 Poojabs5 were clearly aware of the risk from Bacterial Host Cell Genomic DNA “impurities”.

Keep reading

The bulk of credible science finds vaccines ‘can and do’ cause autism 

It’s amazing how many media figures remain so uninformed on the proven links between vaccine and autism. Without knowing the subject thoroughly, they keep falsely claiming the links have been “debunked.” 

Quite the opposite. 

I understand, because I was surprised, too, at what I learned when I was first assigned to cover the subject of vaccine safety at CBS News in 2001. At the time, I knew nothing about how vaccines work, scientific studies linking them to autism and many side other effects, or the medical and industry complex set up to defend them at any cost.

As an investigative reporter looking into this topic independently for more than two decades, I have helped expose a lot of what many are desperate to cover up. Some of my work on the topic has received journalism awards, and it has been cited favorably in the New England Journal of Medicine.

The news that’s been revealed in this time period, including compelling studies, testimony, court cases, and other evidence, is now easily accessible to any reporter who knows better than to simply google and get the industry and medical establishment approved narratives; or rely upon information from the vast network of groups, organizations, and fake “fact checkers,” ultimately set up by industry to spin us all.

With Donald Trump about to enter a second term in office, appointing and relying upon figures in public health who are familiar with the facts on these controversies (and willing to act upon them), we are already being exposed to incessant and increasingly desperate propaganda. 

The propagandists have important connections and plenty of money to spend to wield influence, as they long have, with federal agencies, members of Congress, and in media. They support fake “fact check” groups like Health Feedback and Science Feedback, dominate social media narratives, provide “journalism resources” that give false information, control medical information distributed by our once-esteemed public health agencies, influence medical associations, and back nonprofits that are designed to sound independent but put out industry misinformation. 

They have proven they will go to any lengths to protect their billion dollar profits and to try to stop any disruption of the corrupt medical establishment built to support them. 

Keep reading

First Needle-Free Patch RSV Vaccine Being Created

The U.S. National Institutes of Health (NIH) has granted the Biotech company Vaxxas Pty. Ltd. of Australia a worldwide license to a respiratory syncytial virus (RSV) antigen known as DS2. The license will allow for the firm to create the first needle-free and room-temperature stable RSV vaccine using a novel and “cutting edge” high-density microarray patch (HD-MAP). The DS2 antigen was developed at the NIH’s Vaccine Research Center and is designed to elicit a stronger and durable immune response than the currently approved DS-Cav1.1

Vaxxas’ HD-MAP technology is a needle-free vaccine consisting of thousands of tiny projections on a small patch. Each of the micro projections is coated with a dried vaccine formulation. The patch is applied to the skin then delivers the vaccine to immune cells located just beneath the skin’s surface.

The needle-free vaccine platform has gone through five Phase I clinical trials including a second-generation COVID-19 biologic candidate, as well as microarray versions of vaccines for influenza, measles, and rubella. Vaxxas plans to advance its HD-MAP RSV vaccine to a Phase I clinical study after completing preclinical development.1

Keep reading

Most U.S. Health Care Workers Reject COVID-19 Booster Shot This Year

A recent study published in U.S. Centers for Disease Control and Prevention’s (CDC) Morbidity and Mortality Weekly Report (MMWR) showed a decline in the uptake of COVID-19 shots among health care workers in the United States this year.1 During the 2023–2024 respiratory virus season, fewer than one in six health care personnel working in acute care hospitals and nursing homes reported receiving a COVID booster, and fewer than one-half of health care personnel working in nursing homes had received a flu shot.2

Findings from the study highlighted that only 15.3 percent of health care workers in acute care hospitals, 10.5 percent in nursing homes, and 12.7 percent of licensed independent practitioners reported receiving the updated COVID booster shot, a sharp drop compared to previous seasons.3 In the 2022-2023 respiratory virus season, 17.8 percent of health care workers in hospitals and 22.8 percent in nursing homes had received a COVID booster.4

This decrease comes after the expiration of a vaccine mandate for health care workers in June 2023, which had been implemented by the Biden administration during the earlier phases of the pandemic in 2021 and 2022. The end of government-funded COVID shots also likely played a role in this lower COVID shot uptake.5

Keep reading

‘A Little Dystopian’: Jeff Bezos, Bill Gates Bankrolling Methane Vaccine for Cattle

Amazon founder Jeff Bezos is investing $9.4 million to develop a vaccine designed to reduce the number of methane-producing microbes in a cow’s stomach, Agriland reported.

The funding comes from his Bezos Earth Fund, a philanthropy he established with $10 billion in 2020. The fund intends to distribute all of its money by 2030, by funding projects to “fight climate change and protect nature.”

Researchers at the United Kingdom’s Pirbright Institute and Royal Veterinary College, and New Zealand’s AgResearch are among the groups receiving funding to research how a vaccine could reduce the methane emitted by cows as they digest and expel food through manure, flatulence and burping.

“Vaccines have proven to be an incredibly cost-effective way to deliver global health solutions,” said Bezos Earth Fund President and CEOAndrew Steer in a press release. “If we can apply this approach to vaccinate cattle and reduce emissions, the scalability and impact could be phenomenal.”

Although scientists have sporadically researched methane vaccines for over four decades, no vaccine yet exists. The project’s first goal is to show that such a vaccine is possible.

“This grant is a moonshot for proof-of-concept — risky bets like this are essential to tackling the climate crisis,” Steer said, according to Agriland.

The researchers will study how methanogens, or methane-producing microbes, colonize the digestive tract of calves and how their immune system responds to those methanogens.

Keep reading

FDA approves Gates-backed bird flu vaccine trial: ‘Disaster waiting to happen’

The FDA has approved the first phase of human trials for a self-amplifying mRNA bird flu vaccine developed by Arcturus Therapeutics, funded by the US government and the Gates Foundation. This vaccine, targeting the H5N1 virus, introduces an enzyme prompting cells to produce more mRNA, leading to sustained antigen production, which experts warn could lead to prolonged immune activation and unknown health risks.

Epidemiologist Dr. Nicolas Hulscher described the FDA’s approval as an opportunity for Arcturus to “experiment with injecting humans with H5N1 bird flu replicon mRNA.” The clinical study is funded by the Biomedical Advanced Research and Development Authority (BARDA), a division of HHS focused on pandemic preparedness. Arcturus also recently received a $928,563 grant from the Gates Foundation, which has long supported mRNA research.

Arcturus claims self-amplifying mRNA vaccines can provide immunity with smaller doses. However, Hulscher warned that even a small dose might be more hazardous due to the vaccine’s self-replicating nature, as the extent of antigen production cannot be precisely measured or controlled.

Keep reading

New Study: A Systematic Review of Autopsy Findings in Deaths Following COVID-19 Vaccination

“Contributed risk from other factors, however, does not exonerate the vaccine, which was used on patients with, and without those risk factors.”

Introduction: Investigating Unanswered Questions

The COVID-19 vaccination program is one of the largest global public health initiatives in history. With over 13 billion doses administered worldwide, serious adverse events must be systematically studied to ensure safety. A newly published systematic review, A Systematic Review of Autopsy Findings in Deaths After COVID-19 Vaccination, by Hulscher et al., examines the role of vaccines in post-mortem cases.

This study reviews 325 autopsy cases, concluding that 73.9% of the deaths were causally linked to COVID-19 vaccination. The leading causes of death included sudden cardiac events, thromboembolic complications, myocarditis, and immune-mediated conditions such as vaccine-induced immune thrombotic thrombocytopenia (VITT). These findings underscore the importance of continuous monitoring and investigation.

Key Findings and Their Context

Of the 325 cases reviewed, causality was assessed using clearly described, standardized criteria, revealing:

  • Sudden cardiac death accounted for 35% of vaccine-related cases.
  • Thromboembolic events (pulmonary embolism and VITT) represented significant contributors at 12.5% and 7.9%, respectively.
  • Myocardial infarction (12%), myocarditis (7.1%), and multisystem inflammatory syndrome (4.6%) were also implicated.

These findings raise sound concerns. Causality assessments in autopsy studies rely on detailed pathological examinations and clinical correlation. These methods are robust in spite of a few hypothetical limitations, such as increased risk due to pre-existing conditions, which may be understudied due to incomplete medical histories.

Keep reading

Arcturus Therapeutics is seeking approval from the FDA to go ahead with self-replicating bird flu vaccine trials

Self-amplifying RNA (“saRNA”), also termed self-replicating RNA (“srRNA”), and self-amplifying mRNA (“sa-mRNA” or “samRNA”) are synonymous terms. Both refer to a synthetic mRNA molecule engineered to replicate itself within host cells.  Vaccines using this self-replicating technology are also called “replicon” vaccines.

In November 2023, Japan approved the use of the first saRNA vaccine against covid.  The vaccine is called Kostaive and is also known as ARCT-154 or, in Vietnam, VBC-COV19-154. It is a CSL and Arcturus Therapeutics vaccine.  At the time of the approval, researchers were hopeful that this was only the beginning for saRNA treatments for infectious diseases and even cancers.  The vaccine, which the Japanese are referring to as the “third atomic bomb,” began to be rolled out in Japan in October 2024 as part of its autumn covid vaccination programme.

There is only explicit mention of Kostaive using STARR mRNA technology. However, it is likely that the Kostaive “vaccine” uses both of Arcturus Therapeutics’ proprietary technologies: STARR (self-transcribing and replicating RNA) mRNA technology and LUNAR (lipid-mediated universal RNA delivery) delivery system.

LUNAR is a nanoparticle delivery system that enables the efficient and targeted delivery of mRNA to cells. STARR is a self-replicating RNA platform that combines with LUNAR to drive “therapeutic” protein expression.

Keep reading

FDA Greenlights New Bill Gates-Funded ARCT-2304 Self-Replicating samRNA ‘Pandemic’ H5N1 Bird Flu Jab

Arcturus Therapeutics, a company specializing in mRNA-based pharmaceuticals, quietly announced Monday that the U.S. Food and Drug Administration (FDA) has granted approval for its Investigational New Drug (IND) application for ARCT-2304, a self-amplifying mRNA (sa-mRNA) injection targeting the H5N1 avian influenza “bird flu” virus.

The FDA has recently come under fire for “failing to meet safety requirements” and “failing to prioritize scientific data quality delivered from FDA laboratories,” according to the U.S. House of Representatives Committee on Energy and Commerce.

The new Arcturus trial, funded by the Biomedical Advanced Research and Development Authority (BARDA), aims to assess ARCT-2304’s efficacy in preventing pandemic influenza and plans to enroll around 200 healthy adults across the United States.

“Arcturus is actively engaged with the U.S. government to prepare for the next pandemic, and clearance to proceed into the clinic with our STARR® self-amplifying mRNA technology is a key step in this important process,” said Joseph Payne, President & CEO of Arcturus Therapeutics in a press release.

“The Phase 1 clinical trial is designed to evaluate the safety, reactogenicity, and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian influenza.”

Keep reading

NATO & Vaccines: The Twin Sacred Cows

On February 9, 1990, U.S. Secretary of State James Baker assured Mikhail Gorbachev that if the Soviet leader would cooperate with German unification, NATO would not expand “one inch eastward.” This was just one of many assurances of Soviet security made by Western leaders to Gorbachev and other Soviet officials throughout the process of German unification in 1990 and on into 1991.

On December 12, 2017, the National Security Archive at George Washington University declassified U.S., Soviet, German, British and French documents about these assurances. As the National Security Archive reported at this time:

The documents show that multiple national leaders were considering and rejecting Central and Eastern European membership in NATO as of early 1990 and through 1991, that discussions of NATO in the context of German unification negotiations in 1990 were not at all narrowly limited to the status of East German territory, and that subsequent Soviet and Russian complaints about being misled about NATO expansion were founded in written contemporaneous memcons and telcons at the highest levels. 

The documents reinforce former CIA Director Robert Gates’s criticism of “pressing ahead with expansion of NATO eastward [in the 1990s], when Gorbachev and others were led to believe that wouldn’t happen.” The key phrase, buttressed by the documents, is “led to believe.”

As we now know, the U.S. broke these assurances—a decision characterized by George Kennan, America’s chief architect of Soviet containment policy during he Cold War—as “A Fateful Error” in his Feb. 5, 1997 New York Times editorial.

Keep reading